Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Merck
Baxter
Harvard Business School
Johnson and Johnson

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Litigation Details for Ahold USA, Inc. v. Medicis Pharmaceutical Corp. (D. Mass. 2013)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Ahold USA, Inc. v. Medicis Pharmaceutical Corp. (D. Mass. 2013)

Docket   Start Trial Date Filed 2013-09-09
Court District Court, D. Massachusetts Date Terminated
Cause 15:1 Antitrust Litigation Assigned To Denise Jefferson Casper
Jury Demand Plaintiff Referred To
Parties AHOLD USA, INC.; BARR LABORATORIES, INC.; IMPAX LABORATORIES, INC.; LUPIN LIMITED; LUPIN PHARMACEUTICALS, INC.; MATRIX LABORATORIES, LTD; MEDICIS PHARMACEUTICAL CORP.; MYLAN, INC.; RANBAXY LABORATORIES, LTD; RANBAXY PHARMACEUTICALS, INC.; RANBAXY, INC.; SANDOZ, INC.; TEVA PHARMACEUTICAL INDUSTRIES, LTD; TEVA PHARMACEUTICALS USA, INC.; VALENT PHARMACEUTICALS INTERNATIONAL, INC.
Patents 5,908,838; 7,541,347; 7,544,373; 7,790,705; 7,919,483; 8,268,804
Attorneys Christopher T. Holding; Lauren G. Barnes; Robert D. Carroll; Sarah K. Frederick; Thomas M. Sobol; William R. Landry
Firms Blish & Cavanagh; Christopher T. Holding; Hagens Berman Sobol Shapiro LLP; Robert D. Carroll; Sarah K. Frederick
Link to Docket External link to docket
Small Molecule Drugs cited in Ahold USA, Inc. v. Medicis Pharmaceutical Corp.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Ahold USA, Inc. v. Medicis Pharmaceutical Corp. (D. Mass. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-09-09 1 Complaint has six patents relating to Solodyn. 86. U.S. Patent No. 5,908,838 (the “’838 Patent”) was …three years it was marketed), U.S. Patent No. 5,908,838 (“’838 Patent”), was invalid and/or unenforceable…838 and ’705 patents (and certain other “patent rights” including other patents and patent applications…the ’838 Patent on December 3, 2008. 88. U.S. Patent No. 7,541,347 (the “’347 Patent”) was …The ’347 Patent expires in 2027. 89. U.S. Patent No. 7,544,373 (the “’373 Patent”) was issued External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Johnson and Johnson
Boehringer Ingelheim
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.